European Heart Journal · 2020 · 75 citations · 37 references
MedicineCell BiologyOncologyCardio-oncologyNeoplasiaStem Cell BiologyCancer Stem Cell BiologyCancer Stem CellsBenign Mesenchymal TumorsBlood Cell Lineage CommitmentCardiac Progenitor Cell DifferentiationCardiac Progenitor CellsCardiac Stem CellsCell-type-specific Transcription FactorsMultipotent Progenitor Cells
AIMS: Cardiac myxomas usually develop in the atria and consist of an acid-mucopolysaccharide-rich myxoid matrix with polygonal stromal cells scattered throughout. These human benign tumours are a valuable research model because of the rarity of cardiac tumours, their clinical presentation and uncertain origin. Here, we assessed whether multipotent cardiac stem/progenitor cells (CSCs) give rise to atrial myxoma tissue. METHODS AND RESULTS: Twenty-three myxomas were collected and analysed for the presence of multipotent CSCs. We detected myxoma cells positive for c-kit (c-kitpos) but very rare Isl-1 positive cells. Most of the c-kitpos cells were blood lineage-committed CD45pos/CD31pos cells. However, c-kitpos/CD45neg/CD31neg cardiac myxoma cells expressed stemness and cardiac progenitor cell transcription factors. Approximately ≤10% of the c-kitpos/CD45neg/CD31neg myxoma cells also expressed calretinin, a characteristic of myxoma stromal cells. In vitro, the c-kitpos/CD45neg/CD31neg myxoma cells secrete chondroitin-6-sulfate and hyaluronic acid, which are the main components of gelatinous myxoma matrix in vivo. In vitro, c-kitpos/CD45neg/CD31neg myxoma cells have stem cell properties being clonogenic, self-renewing, and sphere forming while exhibiting an abortive cardiac differentiation potential. Myxoma-derived CSCs possess a mRNA and microRNA transcriptome overall similar to normal myocardium-derived c-kitpos/CD45neg/CD31negCSCs , yet showing a relatively small and relevant fraction of dysregulated mRNA/miRNAs (miR-126-3p and miR-335-5p, in particular). Importantly, myxoma-derived CSCs but not normal myocardium-derived CSCs, seed human myxoma tumours in xenograft's in immunodeficient NOD/SCID mice. CONCLUSION: Myxoma-derived c-kitpos/CD45neg/CD31neg CSCs fulfill the criteria expected of atrial myxoma-initiating stem cells. The transcriptome of these cells indicates that they belong to or are derived from the same lineage as the atrial multipotent c-kitpos/CD45neg/CD31neg CSCs. Taken together the data presented here suggest that human myxomas could be the first-described CSC-related human heart disease.
37
Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration
Antonio Paolo Beltrami, Laura Barlucchi, Daniele Torella et al. · Cell · 2003 · 3.5K citations · Full text
Statistics notes: Absence of evidence is not evidence of absence
John M. Bland · BMJ · 1995 · 1.8K citations · Full text
miR-126 Regulates Angiogenic Signaling and Vascular Integrity
Jason E. Fish, Massimo Santoro, Sarah U. Morton et al. · Developmental Cell · 2008 · 1.7K citations · Full text
c-kit+ cells minimally contribute cardiomyocytes to the heart
Jop H. van Berlo, Onur Kanisicak, Marjorie Maillet et al. · Nature · 2014 · 799 citations · Full text